Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin"

Affiliations

¹ Coagulation Unit, Hematology Center, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
² Department of Medicine, Soonchunhyang University Gumi's Hospital, North Kyungsang Province, South Korea.
³ McMaster University, Population Health Research Institute, Hamilton, ON, Canada.
⁴ Lankenau Medical Center, Thomas Jefferson Medical College, Wynnewood, PA.
⁵ Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
⁶ Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyFaculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
⁷ Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
⁸ Department of Medicine, McMaster University, Hamilton, ON, CanadaKarolinska Institutet, Stockholm, Sweden.

Comment

Ammar Majeed et al. Circulation. 2014.

. 2014 Sep 2;130(10):e95.

doi: 10.1161/CIRCULATIONAHA.114.010280.

¹ Coagulation Unit, Hematology Center, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
² Department of Medicine, Soonchunhyang University Gumi's Hospital, North Kyungsang Province, South Korea.
³ McMaster University, Population Health Research Institute, Hamilton, ON, Canada.
⁴ Lankenau Medical Center, Thomas Jefferson Medical College, Wynnewood, PA.
⁵ Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
⁶ Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyFaculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
⁷ Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
⁸ Department of Medicine, McMaster University, Hamilton, ON, CanadaKarolinska Institutet, Stockholm, Sweden.

No abstract available

Comment on

Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S. Majeed A, et al. Circulation. 2013 Nov 19;128(21):2325-32. doi: 10.1161/CIRCULATIONAHA.113.002332. Epub 2013 Sep 30. Circulation. 2013. PMID: 24081972 Clinical Trial.
Letter by Hifumi et al regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin".
Hifumi T, Takada H, Kiriu N. Hifumi T, et al. Circulation. 2014 Sep 2;130(10):e94. doi: 10.1161/CIRCULATIONAHA.113.008378. Circulation. 2014. PMID: 25210102 No abstract available.